Declines in life expectancy seen for males and females, and for all race and Hispanic-origin groups
Pathway Programs for Medical School Diversity Disrupted by Pandemic
Programs targeting elementary and middle school-aged children more likely to be canceled
Cardiovascular Benefits of Statins Outweigh Low Risk for Muscle Symptoms
Only one of 15 muscle symptom-related reports by study participants assigned to statins believed to be due to statins
Drinking at Least Two Cups of Tea Daily Linked to Reduced Mortality Risk
Inverse association seen for mortality from all cardiovascular disease, ischemic heart disease, stroke
Polypill Cuts Cardiovascular Event Risk in Seniors With Recent MI
Polypill comprising aspirin, ramipril, atorvastatin effective for secondary prevention of cardiovascular disease in older adults
Guidance Developed for Addressing Use of Nonstatin Therapies
Expert consensus decision pathway developed for patients currently taking statins and needing additional treatment
Dapagliflozin Cuts CV Risk in Heart Failure With Preserved LVEF
Risk reduced for primary outcome of worsening heart failure or cardiovascular death
Acetazolamide Helps Treat Volume Overload in Heart Failure
Rate of successful decongestion higher with addition of acetazolamide to loop diuretic in patients with acute decompensated heart failure
Device-Measured Physical Activity Tied to Heart Failure Risk
Risk reduced for 150 to 300 min/week of moderate-intensity physical activity and for 75 to 150 min/week vigorous-intensity physical activity
Cholesterol Concentrations Improved in U.S. Adults From 2007 to 2018
Among adults taking statins, rates of lipid control lower for women versus men, Blacks and other Hispanics versus Whites